MX357376B - Composicion farmaceutica para uso en inflamacion y dolor. - Google Patents

Composicion farmaceutica para uso en inflamacion y dolor.

Info

Publication number
MX357376B
MX357376B MX2011006758A MX2011006758A MX357376B MX 357376 B MX357376 B MX 357376B MX 2011006758 A MX2011006758 A MX 2011006758A MX 2011006758 A MX2011006758 A MX 2011006758A MX 357376 B MX357376 B MX 357376B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
pain
use against
against inflammation
composition
Prior art date
Application number
MX2011006758A
Other languages
English (en)
Other versions
MX2011006758A (es
Inventor
Angélica Arzola Paniagua María
Pablo Senosiain Peláez Juan
Raúl García Salgado López E
Original Assignee
Laboratorios Senosiain S A De C V Star
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to MX2011006758A priority Critical patent/MX357376B/es
Application filed by Laboratorios Senosiain S A De C V Star filed Critical Laboratorios Senosiain S A De C V Star
Priority to RU2013157013/15A priority patent/RU2604149C2/ru
Priority to BR112013033007A priority patent/BR112013033007A2/pt
Priority to PE2013002871A priority patent/PE20141530A1/es
Priority to ES201390103A priority patent/ES2441917B1/es
Priority to PCT/IB2012/053157 priority patent/WO2012176155A1/es
Priority to ARP120102254A priority patent/AR086733A1/es
Publication of MX2011006758A publication Critical patent/MX2011006758A/es
Priority to CL2013003671A priority patent/CL2013003671A1/es
Priority to NI201300142A priority patent/NI201300142A/es
Priority to GT201300318A priority patent/GT201300318A/es
Priority to DO2013000309A priority patent/DOP2013000309A/es
Priority to CR20130687A priority patent/CR20130687A/es
Priority to CO13297886A priority patent/CO6831987A2/es
Publication of MX357376B publication Critical patent/MX357376B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una combinación y composición farmacéutica y particularmente a una combinación de un analgésico y un antiinflamatorio seleccionado de ketorolaco y meloxicam o piroxicam, y vehículos o excipientes farmacéuticamente aceptables. También se refiere a un proceso de fabricación de una composición farmacéutica y al uso de dicha composición para elaborar un medicamento útil para tratar los padecimientos de dolor e inflamación.
MX2011006758A 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor. MX357376B (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (es) 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor.
RU2013157013/15A RU2604149C2 (ru) 2011-06-22 2012-06-21 Фармацевтическая композиция против воспаления и боли и способ ее приготовления (варианты )
BR112013033007A BR112013033007A2 (pt) 2011-06-22 2012-06-21 composição farmacêutica para uso contra inflamação e dor
PE2013002871A PE20141530A1 (es) 2011-06-22 2012-06-21 Composicion farmaceutica para uso en inflamacion y dolor
ES201390103A ES2441917B1 (es) 2011-06-22 2012-06-21 Composición farmacéutica para uso en inflamación y dolor
PCT/IB2012/053157 WO2012176155A1 (es) 2011-06-22 2012-06-21 Composición farmacéutica para uso en inflamación y dolor
ARP120102254A AR086733A1 (es) 2011-06-22 2012-06-22 Combinacion farmaceutica para uso en inflamacion y dolor
CL2013003671A CL2013003671A1 (es) 2011-06-22 2013-12-20 Composicion y combinacion farmaceutica que comprende ketorolaco y meloxicam; proceso para preparar la composicion; uso en el tratamiento de la inflamacion y el dolor.
CO13297886A CO6831987A2 (es) 2011-06-22 2013-12-20 Composición farmacéutica para uso de inflamación y dolor
NI201300142A NI201300142A (es) 2011-06-22 2013-12-20 Composición farmacéutica para uso en inflamación y dolor.
GT201300318A GT201300318A (es) 2011-06-22 2013-12-20 Composición farmacéutica para uso en inflamación y dolor
DO2013000309A DOP2013000309A (es) 2011-06-22 2013-12-20 Composición farmaceutica para uso en inflamación y dolor
CR20130687A CR20130687A (es) 2011-06-22 2013-12-20 Composición farmacéutica para uso en inflamación y dolor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011006758A MX357376B (es) 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor.

Publications (2)

Publication Number Publication Date
MX2011006758A MX2011006758A (es) 2013-01-10
MX357376B true MX357376B (es) 2018-07-06

Family

ID=47422093

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011006758A MX357376B (es) 2011-06-22 2011-06-22 Composicion farmaceutica para uso en inflamacion y dolor.

Country Status (13)

Country Link
AR (1) AR086733A1 (es)
BR (1) BR112013033007A2 (es)
CL (1) CL2013003671A1 (es)
CO (1) CO6831987A2 (es)
CR (1) CR20130687A (es)
DO (1) DOP2013000309A (es)
ES (1) ES2441917B1 (es)
GT (1) GT201300318A (es)
MX (1) MX357376B (es)
NI (1) NI201300142A (es)
PE (1) PE20141530A1 (es)
RU (1) RU2604149C2 (es)
WO (1) WO2012176155A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014193210A1 (es) * 2013-05-27 2014-12-04 Farmacêuticos Rayere, S.A. Composición farmacéutica sinergística de dos analgésicos con distinto perfil farmacocinético

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5091182A (en) * 1990-07-23 1992-02-25 Syntex (U.S.A.) Inc. Dispensing units for ketorolac topical gel formlations
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
MXPA02010828A (es) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
RU2237470C1 (ru) * 2003-01-27 2004-10-10 Купсин Евгений Вениаминович Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
MXPA04009698A (es) * 2004-10-04 2006-04-05 Maria Elena Garcia Armenta Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam.
WO2007148950A1 (es) * 2006-06-20 2007-12-27 Farmacéuticos Rayere, S.A. Composición farmacéutica sinergística de ketorolaco y clonixinato de lisina
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
WO2012176155A1 (es) 2012-12-27
PE20141530A1 (es) 2014-11-12
MX2011006758A (es) 2013-01-10
GT201300318A (es) 2015-05-21
ES2441917A2 (es) 2014-02-06
AR086733A1 (es) 2014-01-15
NI201300142A (es) 2015-02-25
ES2441917R1 (es) 2014-02-19
DOP2013000309A (es) 2014-04-15
CR20130687A (es) 2014-02-21
RU2604149C2 (ru) 2016-12-10
RU2013157013A (ru) 2015-07-27
CO6831987A2 (es) 2014-01-10
ES2441917B1 (es) 2014-11-25
BR112013033007A2 (pt) 2017-01-31
CL2013003671A1 (es) 2014-07-11

Similar Documents

Publication Publication Date Title
MX2013008851A (es) Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias.
MX380273B (es) Conjugados de farmacos anticuerpo (adcs) con inhibidores de ksp.
MX2011007589A (es) Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20.
HK1201065A1 (en) Novel quinoxaline inhibitors of pi3k
MX2016008362A (es) Combinaciones farmaceuticas.
AU2013299841A8 (en) Pharmaceutical combinations comprising a B-Raf inhibitor, an EGFR inhibitor and optionally a PI3K-alpha inhibitor
WO2014012094A3 (en) Tetracycline compounds for treating neurodegenerative disorders
MX2017017138A (es) Conjugados homogeneos especificos de sitio con inhibidores de ksp.
MX352824B (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado común e inflamación.
MX2019008817A (es) Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma.
PH12012501389A1 (en) Hedgehog inhibitors
WO2013083826A3 (en) Glp-1 agonists
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX366309B (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
MX2014010989A (es) Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiatricos.
MX357376B (es) Composicion farmaceutica para uso en inflamacion y dolor.
MX2014005153A (es) Proceso de obtencion y composicion farmaceutica de ketorolaco trometamina y clorhidrato de tramadol sublingual usado para el dolor.
PH12015501538A1 (en) Topical ocular analgesic agents
MX348595B (es) Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
WO2015004634A3 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
GB201312583D0 (en) Combination and composition for treating obesity
MX2014005152A (es) Composicion farmaceutica para el tratamiento de alopatias relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol.
WO2012127498A3 (en) A novel herbal composition for the treatment of kidney stone and other urinary tract disorders
WO2012016314A9 (pt) Compostos derivados do ácido araquidônico substituídos com análogos de coxibes para tratamento de dor
WO2014170820A3 (en) A pharmaceutical combination for treating tuberculosis

Legal Events

Date Code Title Description
FG Grant or registration